Sigilon Therapeutics, Inc.

Paul Kevin Wotton

Omid Veiseh

Robert James Miller

Richard Heidebrecht

Matthias Alexander Oberli

Erika Ellen Johnston

Lauren Emily Barney

David Peritt

Michael Beauregard

Guillaume Carmona

Owen O'Connor

Jared A Sewell

Devyn McKinley Smith

Francisco Caballero Gonzalez

Owen O'CONNOR

Zoe Yin

Devyn Mckinley Smith

Described herein are particles comprising a first compartment, a second compartment, and a compound of Formula (I), as well as compositions and methods of making and using the same. The particles may comprise a cell capable of expressing a therapeutic agent useful for the treatment of a disease, disorder, or condition described herein.

Implantable particles and related methods

The present invention provides compounds, e.g., compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are implantable elements (e.g., devices and materials) comprising the same, as well as methods of use thereof, e.g., for treating or preventing a disease, disorder, or condition.

Compounds, devices, and uses thereof

Growing community of inventors

Boston, MA, United States of America

Paul Kevin Wotton